J&J, Abbott Labs and Allergan Among Wells Fargo's Heaviest Healthcare Stock ... Wall St. Cheat Sheet The Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders. Glaxosmithkline Plc (NYSE:GSK): On 06/30/2011, Wells Fargo Co. ... |
